Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-05

Clinical Trial Update: Effect of Extended Dose Intervals on the Immune Response to Oral Cholera Vaccine [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating how extended dose intervals affect the immune response to an oral cholera vaccine completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Johns Hopkins Bloomberg School of Public Health | Conditions: Cholera, Vibrio Cholerae Infection | Phase 4 | Status: COMPLETED